News
The combination of a β-adrenergic receptors (AR) blocker and a carbonic anhydrase (CA, EC 4.2.1.1) inhibitor in eye drops formulations is one of the most clinically used treatment for glaucoma. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback